Hyperscale Data Also Declares Monthly Cash Dividend of $0.20833 per Share of 10.00% Series E Cumulative Redeemable Perpetual Preferred Stock

LAS VEGAS, Sept. 18, 2026 /PRNewswire/ -- Hyperscale Data, Inc. (NYSE American: GPUS), an artificial intelligence ("AI") data center company anchored by Bitcoin ("Hyperscale Data" or the "Company"), today announced that its Board of Directors (the "Board") has declared a monthly cash dividend of $0.2708333 per share of the Company's outstanding 13.00% Series D Cumulative Redeemable Perpetual Preferred Stock.

Link to NYSE quote for the Company's 13.00% Series D Cumulative Redeemable Perpetual Preferred Stock: https://www.nyse.com/quote/XASE:GPUSpD

The Company also announced today that the Board has declared a monthly cash dividend of $0.20833 per share of the Company's outstanding 10.00% Series E Cumulative Redeemable Perpetual Preferred Stock.

The record date for both dividends is September 30, 2026, and the payment date is Tuesday, October 13, 2026.

For more information on Hyperscale Data and its subsidiaries, Hyperscale Data recommends that stockholders, investors, and any other interested parties read Hyperscale Data's public filings and press releases available under the Investor Relations section at hyperscaledata.com or available at www.sec.gov.

About Hyperscale Data, Inc.

Through its wholly owned subsidiary Sentinum, Inc., Hyperscale Data owns and operates a data center at which it offers colocation and hosting services for the emerging AI ecosystems and other industries. Another of Hyperscale Data's wholly owned subsidiaries, Ault Capital Group, Inc. ("ACG"), is a hybrid private equity firm and operating company that acquires, finances, builds and actively manages businesses across financial services, digital assets, industrial services, hospitality, defense technologies and other sectors.

Hyperscale Data currently expects the divestiture of ACG (the "Divestiture") to occur in 2027. Upon the occurrence of the Divestiture, the Company would be an owner and operator of data centers to support high-performance computing services, as well as a holder of the digital assets and the third wholly owned subsidiary of the Company, Omnipresent Robotics, LLC. Until the Divestiture occurs, the Company will continue to provide, through ACG and its wholly and majority-owned subsidiaries and strategic investments, mission-critical products that support a diverse range of industries, including an AI software platform, equipment rental services, defense/aerospace, industrial, automotive and hotel operations. In addition, ACG is actively engaged in private credit and structured finance through Ault Lending, LLC, a licensed lending subsidiary. Hyperscale Data's headquarters are located at 11411 Southern Highlands Parkway, Suite 190, Las Vegas, NV 89141.

On December 23, 2024, the Company issued one million (1,000,000) shares of a newly designated Series F Exchangeable Preferred Stock (the "Series F Preferred Stock") to all common stockholders and holders of the Series C Preferred Stock on an as-converted basis. The Divestiture will occur through the voluntary exchange of the Series F Preferred Stock for shares of Class A Common Stock and Class B Common Stock of ACG (collectively, the "ACG Shares"). The Company reminds its stockholders that only those holders of the Series F Preferred Stock who agree to surrender such shares, and do not properly withdraw such surrender, in the exchange offer through which the Divestiture will occur, will be entitled to receive the ACG Shares and consequently be shareholders of ACG upon the occurrence of the Divestiture.

Forward-Looking Statements

This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as "believes," "plans," "anticipates," "projects," "estimates," "expects," "intends," "strategy," "future," "opportunity," "may," "will," "should," "could," "potential," or similar expressions. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties.

Forward-looking statements speak only as of the date they are made, and the Company undertakes no obligation to update any of them publicly in light of new information or future events. Actual results could differ materially from those contained in any forward-looking statement as a result of various factors. More information, including potential risk factors, that could affect the Company's business and financial results are included in the Company's filings with the U.S. Securities and Exchange Commission, including, but not limited to, the Company's Forms 10-K, 10-Q and 8- K. All filings are available at www.sec.gov and on the Company's website at hyperscaledata.com.

SOURCE Hyperscale Data Inc.

Share this article

Steven Rockefeller III Appointed to CSTS Enterprises Advisory Board

NEW YORK and HONG KONG, Sept. 18, 2026 /PRNewswire/ -- CSTS Enterprises, the integrated media, entertainment, sports, and travel technology group, today announced the appointment of Mr. Steven Rockefeller III to its Advisory Board. In this capacity, Mr. Rockefeller will provide strategic counsel to the company's leadership as CSTS continues to scale its global portfolio of experiential and technology-driven initiatives.

As a sixth-generation member of the Rockefeller family, Mr. Rockefeller brings extensive experience in investment management, business development, and strategic partnerships. He currently serves as Director of Portfolio Management at Pondmoon Capital, where he focuses on sourcing, evaluating, and structuring private market investment opportunities. His work spans real estate, hedge funds, secondary markets, and alternative investments.

Mr. Rockefeller is also involved in the planning and development of Fieldwood, a long-term master-planned private golf club and residential community in Westchester County, New York. The project integrates a private golf club, residential development, and open space preservation into a comprehensive master plan.

In addition, Mr. Rockefeller serves as an adviser to CodersTrust, an international education technology platform focused on expanding access to digital skills and workforce development, where he supports strategic growth, fundraising, and institutional partnerships.

Previously, Mr. Rockefeller served as Director of Business Development at Zammo.ai, a conversational AI company. He also served as a Senior Advisor to Dot Inc., a technology company pioneering accessibility solutions for the visually impaired through innovative haptic technology. Prior to that, he worked at Cushman & Wakefield, where he advised both U.S.-based companies and Chinese companies seeking to invest in or occupy industrial, retail, and office properties throughout the United States.

Mr. Rockefeller has developed significant experience working across the United States and Asia, particularly China, where he has cultivated strategic relationships with investors, entrepreneurs, corporations, and government stakeholders. His work focuses on connecting investors and companies through strategic partnerships while identifying differentiated investment opportunities.

"Steven's extraordinary breadth of experience, spanning investment management, business development, and strategic partnership is unparalleled," said Abel Zhao, Group CEO and Executive Director of CSTS Enterprises. "We are honored to welcome him to the Advisory Board as we continue to scale our integrated experiential marketing, tourism, data, and technology platforms across Asia and beyond."

Mr. Rockefeller added: "I am truly honored to join the Advisory Board of CSTS Enterprises and to become part of a team with such an impressive history and an even more exciting future ahead. CSTS is entering an important new chapter, and I am excited to contribute my experience and relationships as we explore new markets, build strategic partnerships, and pursue opportunities for continued growth. I am grateful for the opportunity to be part of this journey and look forward to helping guide CSTS through this exciting next chapter."

About CSTS Enterprises

Headquartered in New York, CSTS Enterprises is an integrated media, entertainment, sports, and travel technology group. The company develops and partners with intellectual properties and brands to deliver compelling experiences that connect with local and regional audiences across the world. In addition to its own initiatives, including Generation C and PremierX, it collaborates with international IPs such as the FIFA World Cup, Formula 1, and Waterbomb.

CSTS integrates experiential marketing, tourism, data, and technology to deliver connected audience experiences. The company engages consumers across physical events and digital channels, working with clients to execute at scale across markets, turning complex activations into co-ordinated, measurable outcomes.

SOURCE CSTS Enterprises

Share this article

AUSTIN, Texas, Sept. 18, 2026 /PRNewswire/ -- EigenQ, Inc. ("EigenQ"), an applied quantum technology company building the trusted infrastructure for the Quantum Era, and Silicon Valley Acquisition Corp. ("SVAQ") (Nasdaq: SVAQ), a publicly traded special purpose acquisition company, today announced that EigenQ has entered into a securities purchase agreement (the "Purchase Agreement") with an institutional investor providing financing to support EigenQ's commercialization plans.

The financing is comprised of approximately $45 million in the form of a convertible note, of which approximately $22.5 million was funded upfront with the remaining expected to fund at completion of the previously announced Business Combination between EigenQ and SVAQ. EigenQ expects to use the net proceeds of the financing to accelerate commercialization of its quantum-safe security portfolio, expand delivery capacity alongside its OEM and channel partners, continue R&D across quantum security, communications, networking and sensing, and for working capital and general corporate purposes.

Dr. José R. Rosas-Bustos, Chief Executive Officer of EigenQ. "Today's announcement is a major milestone for EigenQ. It represents an important endorsement of what we have already built and our ability to bring together exceptional partners and institutions to participate in our story. This investment accelerates our mission to offer quantum solutions that can add significant value to companies in the post quantum world."

Dr. Jesse Van Griensven Thé, Chairman of EigenQ, added, "We believe that our key strategic decisions of undertaking a capital-light approach through partnerships and building sustainable operations with optimal capital deployment have led us to our first institutional capital raise. We are excited to bring the EigenQ story to the public markets as this financing full funds us through cash flow breakeven."

Dan Nash, Chief Executive Officer of SVAQ, said, "We believe that the quantum technology market represents a generational opportunity and EigenQ is well positioned to capture it. We remain excited to partner with this leadership team who brings exceptional quantum expertise and the new investor as EigenQ moves towards the public markets."

Building the Quantum Era Infrastructure

- EigenQ develops quantum technologies designed to address critical challenges spanning cybersecurity, digital trust, AI infrastructure, communications, sensing, and advanced computing. Through a growing portfolio of intellectual property, strategic partnerships, and commercial products, EigenQ is building technologies intended to support multiple segments of the emerging quantum economy.

- While the Company's initial commercialization efforts are focused on quantum-resilient security and trusted infrastructure, EigenQ's broader vision extends across a range of quantum-enabled technologies expected to shape future government, enterprise, industrial, and national-security systems.

Commercial Momentum and Anticipated Execution

- EigenQ has focused on innovation and commercialization, translating years of research and development into deployable, market-ready solutions that are aligned with current regulatory requirements, customer needs, and procurement frameworks.

- EigenQ has established strategic collaborations with leading global technology partners including HPE, AMD, WNC, and TD SYNNEX. Importantly, the Company has established pathways for technology integration, manufacturing scale, distribution, and deployment across both public and private sector environments. These technologies are designed to reduce barriers to implementation.

- Initial commercialization efforts are focused on government, defense, and critical infrastructure markets, where regulatory requirements and security mandates are creating immediate demand. Subsequently, the Company expects to expand across enterprise infrastructure, artificial intelligence platforms, financial services, telecommunications, healthcare, industrial systems, and international markets.

Major Strategic Collaborations

- TD SYNNEX & AMD: Announced a collaboration to help organizations evaluate and prepare AMD EPYC processor-based server environments for post-quantum security migration and phased infrastructure modernization.

- WNC Corporation: Partnered to accelerate volume production and go-to-market strategies for quantum-safe servers, appliances, and edge devices.

- HPE & Intel Ecosystem: Aligned technology integrations to support platform retrofitting, secure workload protection, and cryptographic agility across enterprise and public sectors.

The Business Combination

- EigenQ announced a definitive business combination agreement with Silicon Valley Acquisition Corp. valuing the combined company at an estimated $3 billion enterprise value that would take the quantum technology company public on Nasdaq Global Market under the ticker symbol "EIGQ", subject to shareholder approval, regulatory approvals and other customary closing conditions.

- The Business Combination Agreement has been unanimously approved by the Board of Directors of SVAQ and the Board of Directors of EigenQ.

- The proposed transaction, expected to close in the fourth quarter of 2026 pending shareholder and regulatory approvals, would provide EigenQ with additional access to capital while existing shareholders are expected to retain significant ownership stakes.

Advisors

Cohen & Company Capital Markets, a division of Cohen & Company Securities, LLC, is serving as Exclusive Financial Advisor, Lead Capital Markets Advisor and Sole Placement Agent to EigenQ. Ellenoff Grossman & Schole LLP is acting as legal counsel to EigenQ, Greenberg Traurig, LLP is acting as legal counsel to SVAQ and Reed Smith LLP is acting as legal counsel to Cohen & Company Securities, LLC. The Blueshirt Group is providing investor relations advisory services to EigenQ and AUM Media is providing investor relations advisory services to SVAQ.

About EigenQ

EigenQ is an applied quantum technology company building the trusted infrastructure for the Quantum Era. Headquartered in Texas, USA, the company develops and commercializes foundational technologies across quantum security, communications, networking and sensing — helping public and private sectors globally prepare for a future shaped by quantum computing and AI.

Working alongside a global ecosystem of OEMs, technology partners and industry leaders, EigenQ today delivers deployable, market-ready solutions that combine post-quantum cryptography, quantum-derived entropy, hardware-rooted trust, secure identity and cryptographic agility to strengthen existing digital infrastructure.

For more information, visit https://www.EigenQ.com.

About Silicon Valley Acquisition Corp.

Silicon Valley Acquisition Corp. is a blank check company whose business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

Additional Information and Where to Find It

The proposed Business Combination by and between EigenQ and SVAQ will be submitted to the shareholders of SVAQ for their consideration. A registration statement on Form S-4 (the "Registration Statement") is expected to be filed with the SEC, which will include preliminary and definitive proxy statements to be distributed to SVAQ's shareholders in connection with SVAQ's solicitation for proxies for the vote by SVAQ's shareholders in connection with the proposed Business Combination and other matters as described in the Registration Statement, as well as a prospectus relating to the securities to be issued in connection with the completion of the proposed Business Combination. After the Registration Statement has been filed and declared effective by the SEC, SVAQ will mail a definitive proxy statement and other relevant documents to its shareholders as of the record date established for voting on the proposed Business Combination.

SVAQ's shareholders and other interested persons are advised to read, once available, the preliminary proxy statement/prospectus and any amendments thereto and, once available, the definitive proxy statement/prospectus in connection with SVAQ's solicitation of proxies for its extraordinary general meeting of shareholders to be held to approve, among other things, the proposed Business Combination, because these documents will contain important information about SVAQ, EigenQ and the proposed Business Combination. This press release does not contain all the information that should be considered concerning the Business Combination and other matters and is not intended to provide the basis for any investment decision or any other decision in respect of such matters. SVAQ and EigenQ may also file other documents with the SEC regarding the Business Combination. Shareholders may also obtain a copy of the preliminary or definitive proxy statement/prospectus, once available, as well as other documents filed with the SEC regarding the proposed Business Combination and other documents filed with the SEC by SVAQ, without charge, at the SEC's website located at www.sec.gov or by directing a request to Silicon Valley Acquisition Corp., 228 Hamilton Avenue, 3rd Floor, Palo Alto, CA 94301.

Participants in the Solicitation

SVAQ, EigenQ and certain of their respective directors, executive officers and other members of management and employees may, under SEC rules, be deemed to be participants in the solicitations of proxies from SVAQ's shareholders in connection with the proposed Business Combination. Information regarding the persons who may, under SEC rules, be deemed participants in the solicitation of SVAQ's shareholders in connection with the proposed Business Combination will be set forth in SVAQ's proxy statement/prospectus when it is filed with the SEC.

Peter Carlin steps down from Adient board of directors, joins company as CFO on Nov. 16, 2026

PLYMOUTH, Mich., Sept. 18, 2026 /PRNewswire/ -- Adient (NYSE: ADNT), a global leader in automotive seating, today announced that on Oct. 1, 2026, Peter Carlin will be stepping down from Adient's board of directors and joining the company initially as vice president, finance. He will then be appointed executive vice president and chief financial officer of Adient, effective Nov. 16, 2026. Carlin's appointment follows Mark Oswald's departure from Adient as its executive vice president and chief financial officer, also effective Nov. 16, 2026.

"Peter has served on our Board since 2018, providing valuable insights and counsel to the management team and his colleagues on the board," said Frederick A. Henderson, chair of the board of Adient. "On behalf of the leadership team and board, we thank Peter for his significant contributions to Adient to date and look forward to continuing to work with him in his new executive officer role."

"I want to thank and recognize both Peter and Mark for their contributions to Adient over the years. Their efforts with the board and leadership team have helped to steward the company's legacy of strong customer relationships and operational excellence. I look forward to welcoming Peter to our management team as we build on the company's positive momentum and continue to drive the business forward," said Jerome Dorlack, Adient's president and chief executive officer.

Adient's board has taken action to reduce the size of the board to seven directors, effective as of Carlin's resignation on Oct. 1, 2026.

About Adient:

Adient (NYSE: ADNT) is a global leader in automotive seating. With more than 65,000 employees in 29 countries, Adient operates ~200 manufacturing/assembly plants worldwide. We produce and deliver automotive seating for all major OEMs. From complete seating systems to individual components, our expertise spans every step of the automotive seat-making process. We take our products from research and design to engineering and manufacturing — and into millions of vehicles every year. For more information, please visit www.adient.com.

SOURCE Adient

Share this article

OAKLAND, Calif., Sept. 18, 2026 /PRNewswire/ -- PG&E Corporation (NYSE: PCG) declared its third quarter 2026 regular cash dividend of $0.05 per share on the Corporation's common stock. The dividend is payable on October 15, 2026, to shareholders of record as of September 30, 2026.

In addition, PG&E Corporation's utility subsidiary, Pacific Gas and Electric Company (PG&E), declared the regular preferred stock dividend for the three-month period ending October 30, 2026, to be payable on November 15, 2026, to shareholders of record as of October 30, 2026. PG&E will pay dividends on its eight series of preferred stock as follows:

About PG&E Corporation

PG&E Corporation (NYSE: PCG) is a holding company headquartered in Oakland, California. It is the parent company of Pacific Gas and Electric Company, an energy company that serves 16 million Californians across a 70,000-square-mile service area in Northern and Central California.

For more information, visit http://www.pgecorp.com.

SOURCE PG&E Corporation

Share this article

DELRAY BEACH, Fla., Sept. 18, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the Enzymes Market is estimated to grow from USD 16.15 billion in 2026 to USD 23.74 billion by 2031, at a CAGR of 8.0% from 2026 to 2031.

Enzymes Market Size & Forecast

- Market Size Available for Years: 2022–2031

- 2026 Market Size: USD 16.15 billion

- 2031 Projected Market Size: USD 23.74 billion

- CAGR (2026–2031): 8.0%

Enzymes Market Trends & Insights:

- The demand for enzymes is expected to grow steadily, supported by increasing adoption across food & beverages, animal feed, biofuels, detergents, textiles & leather, pulp & paper, wastewater treatment, pharmaceuticals, and biotechnology. Enzymes are widely used to improve process efficiency, product quality, and yield while reducing energy, chemical, and resource consumption. Growing demand for processed foods, rising biofuel production, expansion of industrial biotechnology, and increasing focus on sustainable manufacturing are expected to further support market growth.

- The South America is projected to register the highest CAGR of 9.1% during the forecast period.

- The wastewater treatment segment is expected to be the fastest growing, registering a CAGR of 9.2% during the forecast period.

- The plant segment is expected to register the highest CAGR of 8.4% during the forecast period.

- Proteases are expected to be the fastest-growing enzyme type, while Carbohydrases are expected to account for the largest market share during the forecast period.

- Industrial enzymes are expected to account for the largest share of the enzymes market by 2031.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=46202020

The demand for enzymes is poised to grow steadily, supported by increasing adoption across food & beverages, animal feed, biofuels, detergents, textiles & leather, pulp & paper, wastewater treatment, pharmaceuticals, and biotechnology. Enzymes are widely used to improve process efficiency, product quality, and yield while reducing energy, chemical, and resource consumption. Growing demand for processed foods, rising biofuel production, expansion of industrial biotechnology, and increasing focus on sustainable manufacturing are expected to further support market growth.

Enzymes are available in a wide range of types and sources, including carbohydrases, proteases, lipases, polymerases & nucleases, and other enzymes, derived from microorganisms, plants, and animals. Increasing use of engineered and application-specific enzymes, advances in fermentation and enzyme engineering technologies, and growing adoption of enzyme-based solutions in emerging applications such as wastewater treatment are expected to create further opportunities for market participants.

By industrial enzyme application, food & beverages is expected to account for the largest market share during the forecast period.

Food & beverages is expected to remain the leading application for industrial enzymes, supported by their widespread use in bakery, dairy, brewing, starch processing, and other food manufacturing processes. Increasing demand for improved processing efficiency, product consistency, yield, and quality continues to support the extensive use of enzymes across the food & beverage industry.

By product type, industrial enzymes are expected to account for the largest market share during the forecast period.

Industrial enzymes are expected to maintain their dominant position due to their broad application across food & beverages, animal feed, detergents, biofuels, textiles, pulp & paper, and wastewater treatment. Their established use in large-scale industrial processes and ability to improve process efficiency, productivity, and resource utilization support their continued market presence.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=46202020

By region, Asia Pacific is expected to account for the second-largest market share during the forecast period.

The Asia Pacific region will account for the second-largest share of the enzymes market during the forecast period. Growth in the Asia Pacific market is supported by expanding food & beverage processing, animal feed production, biofuel manufacturing, and industrial biotechnology activities. Rising industrialization, increasing adoption of advanced processing technologies, and growing demand for efficient and sustainable production solutions are contributing to enzyme consumption across the region. China, India, Japan, and other emerging economies are expected to provide significant opportunities as manufacturers increasingly adopt enzymes to improve productivity, product quality, and resource efficiency.

Top Companies in the Enzymes Market

The report profiles key players such as BASF SE (Germany), International Flavors & Fragrances Inc. (US), dsm-firmenich (Switzerland), Associated British Foods plc (UK), Novonesis Group (Denmark), and Kerry Group plc (Ireland), among others.

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=46202020

Investment and Funding Context

Alltech is a global animal nutrition and biosolutions company with a portfolio spanning animal nutrition, health, and biological solutions for soil and plants. The company has raised an undisclosed amount in funding, with its latest reported funding round being a grant (prize money) in January 2025 from the US Department of Agriculture. Alltech's investment and innovation activities support the development and commercialization of biological and enzyme-based solutions for animal nutrition and sustainable agriculture.

Revenue Shift Context

The global enzymes market is shifting toward higher-performance, application-specific, and sustainable enzyme solutions, supported by growing demand across food & beverages, animal feed, biofuels, detergents, pharmaceuticals, and industrial applications. Market spending is estimated to increase from USD 16.15 billion in 2026 to USD 23.74 billion by 2031, at a CAGR of 8.0%. This shift reflects increasing adoption of enzymes that improve process efficiency, product quality, yield, and resource utilization, while supporting lower energy and chemical consumption.

Mergers and Acquisitions

Key players are pursuing acquisitions to strengthen their enzyme portfolios, expand customer reach, and enhance their positions across high-growth applications. In February 2025, Novonesis Group agreed to acquire dsm-firmenich's share of the Feed Enzyme Alliance for EUR 1.5 billion (USD 1.69 billion) in cash. The transaction enabled Novonesis to take over the Alliance's sales and distribution activities, integrate them with its existing enzyme innovation and production capabilities, and strengthen its position across the animal biosolutions value chain.

In December 2023, Kerry Group announced an agreement to acquire the global lactase enzymes business of Chr. Hansen and Novozymes, referred to here as Novonesis Group, for EUR 150 million (USD 162.3 million). The acquisition added the NOLA lactase portfolio to Kerry's biotechnology capabilities and strengthened its position in enzyme solutions for lactose-free and sugar-reduced dairy products. The business had approximately EUR 40 million in attributable revenue in 2022 and sales across more than 50 countries.

ENZYMES MARKET: MERGERS AND ACQUISITIONS, JANUARY 2023–AUGUST 2026

Company Revenue Share Details

The enzymes market is moderately fragmented, with leading companies including BASF SE (Germany), International Flavors & Fragrances Inc. (US), dsm-firmenich (Switzerland), Novozymes Group (Denmark), and Kerry Group plc (Ireland). Together, these top five companies are estimated to account for approximately 46% of the market. They compete by offering broad product portfolios, advanced enzymes, extensive global distribution networks, strong regulatory capabilities, and tailored solutions for industrial and specialized needs.

Browse Adjacent Reports @ Food and Beverage Market Research Reports & Consulting

Related Reports:

Food Enzymes Market by Type (Carbohydrases, Proteases, Lipases, Polymerases, & Nucleases), Application (Food & Beverages), Source (Microorganisms, Animals, & Plants), Formulation, Functional Role, and Region - Global Forecast to 2030

Industrial Enzymes Market by Type (Carbohydrases, Proteases, Lipases, Polymerases, and Nucleases), Application (Food & Beverages, Bioethanol, Feed, Detergents, Wastewater, Soil, and Oil Treatment), Source, Formulation, and Region - Global Forecast to 2030

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready.

Huawei Unveils Upgraded Stellar AI Network to Power the Agentic World with Secure, Intelligent Connectivity

SHANGHAI, Sept. 18, 2026 /PRNewswire/ -- At HUAWEI CONNECT 2026, Huawei unveiled its upgraded Stellar AI Network Solution under the philosophy of secure, intelligent connectivity. With stand-out features such as efficient computing production, lossless delivery, and superfast application, this future-ready solution unleashes computing productivity while safeguarding services in the AI era.

Driven by explosive AI adoption, daily token consumption has surged 260-fold in a year. Huawei's upgraded Stellar AI Network—spanning AI Fabric, AI WAN, and AI Campus—responds to this by focusing on intelligent connectivity and security.

Stellar AI Fabric 2.0

- Intelligent connectivity: To tackle challenges like surging networking costs, slow protocol conversion, and traffic retransmissions caused by link flapping, Huawei has introduced the UBG switch SF9300 series. Paired with Ascend A5/A6, it forms a full-series UBG compute-network integrated solution. Specifically, two-layer multi-plane architecture eliminates the core layer, cutting network deployment costs by 30%. The unified protocol reduces end-to-end latency from 20 μs to 11 μs. Link-Layer Retransmission (LLR) achieves zero packet loss during link flaps, reducing annual cluster service downtime by 100 hours. Huawei also unveiled its fully in-house CloudEngine XH9300-EN series NPO switches, delivering three major breakthroughs. First, centralized light-source design lowers interconnect power consumption from 1,000 W to 600 W, saving cluster electricity costs. Second, near-packaged architecture reduces optical-electrical conversion latency by 180 ns, optimizing single-node latency by 26%. Third, pluggable snap-fit structure enables on-site replacement, shortening fault recovery time from days to hours.

- Security: Huawei's Three-Layer Security Guardrail Solution defends against hashrate theft, prompt injection, and model poisoning. Specifically, Network Guardrail features an integrated cryptojacking detection model delivering a 95% detection rate with millisecond-level malicious traffic blocking. Agent Guardrail guards against prompt injection attacks with 95% accuracy at under 150 ms latency. Host Guardrail performs real-time monitoring of malicious processes while keeping CPU usage below 1%. At a real-world customer site, the solution identified 415 high-risk vulnerabilities and 322 threat events in its first seven days—leveraging AI to safeguard AI and ensure secure token production.

Stellar AI WAN

- Intelligent connectivity: Cross-region computing faces issues like severe efficiency loss, high on-premises costs, and expensive private lines. To address these, Huawei's Stellar AI WAN Solution enables lossless delivery of computing power over 1,000 km: The Starnet lossless algorithm eliminates long-distance packet loss, boosting remote computing efficiency to over 95%. The XH computing-network appliance uses the layerwise model partitioning algorithm to run initial and final layers locally, transmitting only high-dimensional vectors over the network. This ensures raw data remains strictly on-premises and reduces initial branch xPU costs fourfold. Furthermore, computation-communication overlapping cuts bandwidth idle time by over 80% and reduces required bandwidth fivefold.

- Security: Huawei's multi-dimensional WAN defense technology counters novel vectors like APTs and HNDL attacks. At the device layer, intrinsic security boards block intrusions in real time, trace threats within minutes at over 95% accuracy, and visualize up to 100-hop attack paths. At the link layer, built-in QKD delivers robust quantum security without extra devices, cutting construction costs by over 60% while extending transmission distance to 80 km. At the network layer, APN6-based data fencing enables network-wide control over traffic paths, ensuring the secure circulation of sensitive data.

Stellar AI Campus Network

- Intelligent connectivity: With enterprise agent adoption expected to approach 50% this year, manual O&M falls short of 24/7 demands, making minute-level fault recovery a must. Huawei meets this by upgrading all-scenario network autonomy across data, models, and tools. Specifically, proprietary network awareness technology supports the collection of over 25 exclusive data types with a 100 ms sampling cycle to precisely detect subtle anomalies. The Deep Causal Pruning (DCP) algorithm optimizes AI models, cutting inference errors by over 20% while boosting troubleshooting accuracy to 95%. iFlow 2.0 distributed simulation technology ensures 24/7 continuous verification of inference paths. This enables network-wide AI-powered operations, slashing MTTR to under 5 minutes and ensuring mission-critical service experience.

- Security: Today's enterprises struggle with the rapid compromise of dumb terminals and hidden malicious interactions by agents. Huawei's Stellar AI Campus Network Asset Security 2.0 solution addresses these through endpoint-network collaborative protection. By embedding AI micro-models into switches, the solution cuts dumb-terminal threat detection time from 5 minutes to under 10 seconds. Powered by proprietary AI Core small models and NPU semantic large models, it fully reconstructs agent interaction scenarios, boosting the malicious command detection rate to 95%. This eliminates hidden risks and safeguards campus networks and services.

Looking ahead, Huawei will continue to innovate its Stellar AI Network products and solutions in line with the "AI for All, All on Secure IP" vision, maximizing the value of every connection together with customers and partners in the AI era.

Share this article

AskGamblers Sportsbook Showdown: A Place to Celebrate Betting Excellence

AskGamblers is shining a spotlight on sportsbooks in the first-ever Sportsbook Showdown. Every brand listed on the website can participate, but only 10 will make the leaderboard, and there will only be one winner.

BELGRADE, Serbia, Sept. 18, 2026 /PRNewswire/ -- AskGamblers, a leading casino and sports betting affiliate, is organising the Sportsbook Showdown, an event designed to celebrate bettors' favourite sports betting sites.

From 14 September until 31 October, bettors can vote for sportsbooks on the AskGamblers website. Their votes will give us the top 10 sportsbooks, and the winner will be announced at the beginning of November.

All sportsbooks listed on the AskGamblers website are participating in the Showdown, and each bettor can vote only once. They will all receive Loyalty Program tokens after voting.

The winner will be crowned the Showdown Champion '26, and it will officially be bettors' favourite sportsbook for the year.

Speaking about the new event, Dijana Radunović, General Manager at AskGamblers, said: "The Sportsbook Showdown is not meant to name the best sportsbook on our website. We already have that at the AskGamblers Awards. We are here to crown 10 bettors' favourite sportsbooks, and ultimately, the Showdown Champion '26. If our players like the brand, then that sportsbook represents betting excellence.

We are very excited about this event, especially since it's the first time we are organising something like this. We can't wait to find out how bettors feel about the sports betting brands on AskGamblers and who our winner for 2026 will be."

About AskGamblers

Dedicated to delivering up-to-date, objective, and precise information, AskGamblers.com aims to guide users toward a secure gaming experience. Our comprehensive approach, which includes evaluations of online casinos, sportsbooks, slots, and bonuses, alongside our reliable Complaint Service, is encapsulated in our guiding principle: "Get the truth. Then play."

For further details about AskGamblers or the Sportsbook Showdown event, please get in touch with Dijana Radunović at [email protected].

This information was brought to you by Cision http://news.cision.com

Share this article

BIRKENSTOCK OPENS A NEW STORE IN THE HEART OF BERLIN

LINZ AM RHEIN, Germany and BERLIN , Sept. 18, 2026 /PRNewswire/ -- More than 250 years of shoemaking tradition meet Berlin's creative and historical energy: The new store in Berlin-Mitte combines BIRKENSTOCK's long-standing shoemaking tradition with the cultural and creative identity of the German capital.

On September 16, 2026, BIRKENSTOCK has opened one of its largest stores in Europe on Münzstraße in Berlin, with a floor area of approximately 125 square meters. With this new location, the inventor of the footbed is leaving a distinctive mark on its home market and blending over 250 years of shoemaking tradition with the cultural and creative identity of the German capital. The theme of craftsmanship runs like a common thread through the entire store concept — from the interior design to collaborative projects with the local creative scene.

GROUNDED IN CULTURE: BERLIN AS A KEY SOURCE FOR DESIGN INSPIRATION

Under the guiding principle "Grounded in Culture," the store design of the new location draws on various references rooted in Berlin's culture and combines them with BIRKENSTOCK's characteristic materials and craftsmanship — which have been part of contemporary and everyday culture since the 1970s. The warm exposed concrete evokes the architectural character of Berlin-Mitte, and the store reinterprets the typical planters that lined the streets during the DDR era through moss-covered elements. Cork and jute — materials inextricably linked to BIRKENSTOCK's iconic footbed — are featured throughout the interior, as are naturally formed wooden structures. 

Beyond these material and aesthetic references, the design pays homage to the history that has shaped Berlin while engaging in a direct dialogue with the city's creative scene. Furniture and objects developed in collaboration with Berlin-based designers and studios bring contemporary Berlin directly into the store. Music, too — a defining part of the city's cultural identity — becomes a design element and can be experienced throughout the space.

CONNECTING THROUGH CRAFT: ARTISANRY AS A UNIFYING ELEMENT

To celebrate the store's opening, BIRKENSTOCK is bringing selected creative partnerships, initiatives, and projects to life while seeking to engage with fans and visitors: Berlin-based Yellow Nose Studio, which also designed seating and accessories for the store, is hosting a workshop where participants can create small wooden tags. Analog Glass has designed two chandeliers for the space that resemble the iconic shape of the BIRKENSTOCK footbed and are made of glass that was hand-blown in Berlin. The Berlin-based DJ collective and music project Sound Metaphors is curating the soundtrack for the opening, which will be played through a H.A.N.D. HIFI sound system custom-built for BIRKENSTOCK. Crafted from cork and designed in the footbed's signature blue, it also visually connects key elements of the BIRKENSTOCK world.

In addition, the store offers a wide selection from the BIRKENSTOCK product universe: from popular classics and seasonal new arrivals to an exclusive selection from the 1774 line and the Care Essentials collection.

This conceptual approach results in a store that is not only shaped by Berlin but is created in cooperation and dialogue with the city: a vibrant and multifaceted place with analog references for all the senses, inviting visitors to discover, experience, linger, and engage in conversation — all to enable even more people worldwide to walk naturally on the original footbed.

INFORMATION FOR EDITORIAL TEAMS

Open from September 16, 2026

Store address: Münzstraße 20, 10178 Berlin, Germany

Opening hours: Monday through Saturday, 11 a.m. – 7 p.m.

Store photos: Download

Image credits: BIRKENSTOCK/Clemens Poloczek

ABOUT BIRKENSTOCK

BIRKENSTOCK is a universal brand which embraces all consumers regardless of geography, gender, age, and income, and which is committed to a clear purpose – maintaining foot health. Deeply rooted in studies of the biomechanics of the human foot and footed on a family tradition of shoemaking that can be traced back to 1774, BIRKENSTOCK is a timeless "super brand" with a brand universe that transcends product categories and ranges from entry-level to luxury price points while addressing the growing need for a conscious and active lifestyle. Function, quality and tradition are the core values of the lifestyle brand which features products in the footwear, sleep systems and natural cosmetics segments. BIRKENSTOCK is the inventor of the footbed and has shaped the principle of walking as intended by nature ("Naturgewolltes Gehen").

With around 7,200 employees worldwide, BIRKENSTOCK is convinced that how things are made matters as much as the product itself. To ensure these quality standards, the Group operates a vertically integrated manufacturing base and produces all footbeds in Germany. In addition, BIRKENSTOCK assembles over 95% of all products in Germany and sources over 90% of materials and components from Europe. Raw materials are processed to the highest environmental and social standards in the industry. For materials testing BIRKENSTOCK operates state-of-the-art scientific laboratories.

Headquartered in Linz am Rhein, the BIRKENSTOCK Group also operates its own sales offices in the United States and Canada as well as in Brazil, Japan, South Korea, Denmark, Poland, Switzerland, Sweden, Spain, the United Kingdom, France, the Netherlands, Dubai, Singapore, India, China, and Australia.

Birkenstock Group B.V. & Co. KG

Burg Ockenfels, Linz am Rhein, Germany

Please find further information at www.birkenstock-group.com

You can find our online shop at www.birkenstock.com

SOURCE BIRKENSTOCK Group

Share this article

Best Prenatal Multivitamin (2026): Needed Named The Leading Choice for Comprehensive Prenatal Nutrition by Better Business Advice

NEW YORK, Sept. 18, 2026 /PRNewswire/ -- Better Business Advice has recognized Needed Prenatal Multivitamin as the leading choice for comprehensive prenatal nutrition in 2026, citing a 22-nutrient formula available as three daily capsules or one scoop of vanilla powder. The product range has also expanded with Prenatal Multi Gummies, a distinct 17-nutrient formula taken as three gummies per day.

Best Prenatal Multivitamin

- Needed - a women-led nutritional supplement company offering a 22-nutrient Prenatal Multivitamin in capsule and powder form, as well as a 17-nutrient Prenatal Multivitamin Gummy for preconception, pregnancy, and postpartum support.*

The recognition focuses on nutrient coverage, clinically informed amounts, ingredient forms, quality controls, and practical use across preconception, pregnancy, and postpartum. Needed also takes a deliberate approach to nutrients commonly placed inside prenatal supplements, offering iron and omega-3 separately to allow more individualized dosing.

Prenatal labels can appear comprehensive at first glance. However, ingredient count alone does not reveal nutrient amounts, forms, or compatibility with an individual diet. Better Business Advice found that Needed combines broad nutritional coverage with two formats designed to accommodate different routines, including periods of nausea or pill fatigue.

22 Nutrients at Clinically Informed Levels

Comprehensive prenatal nutrition requires more than a lengthy ingredient list. Needed's Prenatal Multi combines 22 vitamins and minerals with clinically informed levels of nutrients associated with maternal nutrition, fetal development, immune function, thyroid function, and energy metabolism.*

Each serving contains 200 mg of choline, 100 mcg of vitamin D3, 40 mg of vitamin B6, 200 mcg of selenium, 25 mg of zinc, and 150 mcg of active vitamin B12. The formula also includes vitamins A, C, E, and K, several B vitamins, iodine, magnesium, chromium, copper, and other nutrients relevant throughout the perinatal period.

Choline carries particular importance during pregnancy. The nutrient supports fetal brain and nervous system development, yet many prenatal formulas contain limited amounts.* Needed provides 200 mg per serving, creating a meaningful contribution toward the 450 mg Adequate Intake established for pregnancy. Food sources remain necessary for meeting total daily needs.

Folate appears as Optifolin+®, a bioavailable methylfolate enriched with choline. Methylfolate is an active form that does not require the same conversion process as folic acid before use by the body. Folate supports normal cell division, red blood cell formation, and early fetal development.*

Current public health guidance specifically recommends folic acid before and during early pregnancy. Total folate intake and supplement format should be reviewed with a qualified healthcare practitioner.

Needed states that the Prenatal Multivitamin delivers eight times more nutrition than the average of leading prenatals.† The comparison measures amounts of selected vitamins and minerals per daily serving relative to pregnancy Recommended Dietary Allowances.

Capsule and Powder Formats for Daily Use

The same 22-nutrient formula is available in two formats, giving customers a choice between three capsules per day and one scoop of vanilla-flavored powder. Both options are designed to provide consistent nutritional support without requiring a different prenatal for each trimester.*

The capsule format offers a compact routine for customers comfortable with traditional supplements. Three capsules make up a complete daily serving. Original and citrus-scented options are available, allowing some flexibility around scent preferences during pregnancy.

The powder provides the same core nutrition in one daily scoop. Needed recommends blending the vanilla powder with milk, a smoothie, oatmeal, or another suitable food. Hot foods, hot beverages, and cooking are not recommended. The powder should also be taken with food rather than on an empty stomach.

For customers moving from a less nutrient-dense prenatal, Needed recommends beginning with half a scoop before progressing to a complete serving. Guidance from a healthcare practitioner remains important during any supplement transition.

Lastly, Prenatal Multi Gummies are offered in Orange Passionfruit Pineapple and Strawberry Banana flavors. Needed states that the formula provides four times more nutrition than the average leading prenatals§, including capsules, based on nutrient amounts per daily serving relative to pregnancy Recommended Dietary Allowances.

Nausea, scent sensitivity, and pill fatigue can make a routine harder to maintain. Capsules offer portability, powder can fit naturally into breakfast or another daily meal, and gummies provide a chewable option when the other formats are less practical. Better Business Advice noted that the range supports the same goal: making consistent prenatal nutrition more manageable across changing stages and preferences.

Streamlined and Expanded Prenatal Options

Needed offers prenatal formulas designed around different preferences for serving size and nutrient coverage. Prenatal Multivitamin condenses 22 nutrients into three daily capsules, with the same nutrition available in one scoop of powder. Prenatal Multi Gummies offer a separate 17-nutrient formula in three gummies, while Prenatal Multivitamin Pro provides a 26-nutrient formula across eight capsules.

The streamlined Prenatal Multivitamin was developed from the original Pro formula for customers seeking clinically informed nutrient levels without a larger capsule routine. Three capsules deliver eight times more nutrition than the average of leading prenatals.†

Prenatal Multivitamin Pro is designed for customers comfortable with eight capsules per day. The Pro formula provides more choline and magnesium and includes calcium, lutein, and zeaxanthin. A complete serving contains 400 mg of choline, compared with 200 mg in the streamlined Prenatal Multivitamin.

Both formulas keep iron and omega-3 separate. Needed offers dedicated Iron and Prenatal Omega-3 products so dosing can reflect individual needs, bloodwork, diet, and guidance from a healthcare practitioner.

Research, Practitioner Input, and Quality Controls

Needed develops products through published research, original clinical work, and input from a network of more than 20,000 women's health practitioners. The network includes obstetrician-gynecologists, midwives, dietitians, nutritionists, and other professionals working across fertility, pregnancy, and postpartum care.

Needed Labs conducted an Institutional Review Board-approved study involving 235 pregnant women. The company reports that women receiving studied amounts of vitamin D, vitamin B6, selenium, and zinc showed higher blood nutrient levels than women in a standard prenatal group. The findings support the company's use of clinically informed nutrient levels without establishing guaranteed clinical outcomes.

Product quality was another factor highlighted by Better Business Advice. Needed states that every batch undergoes third-party testing for purity and potency and passes more than 2,000 quality checkpoints. The process covers raw-material qualification through finished-product release.

Manufacturing takes place in the United States in Good Manufacturing Practice-certified facilities. The Prenatal Multivitamin has also received the Clean Label Project® Purity Award and Pesticide-Free Award.

Needed was founded by Julie Sawaya and Ryan Woodbury, two mothers and trained nutritionists. Product development began after both founders encountered limited nutrition guidance during personal fertility journeys. More than three years went into developing the Needed Nutritional System for fertility, pregnancy, postpartum, and longer-term women's health.

The company is a Certified B Corporation, Certified Climate Neutral, and a member of 1% for the Planet. Needed products are also HSA/FSA eligible through Truemed for qualified customers. One-time purchases and subscription schedules are available, with longer subscription supplies offering greater savings. Current prices, eligibility requirements, and terms should be confirmed before purchase.

Read the full review at Better Business Advice.

* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

† Eight times more nutrition refers to the average amount of vitamins and minerals provided per daily serving, measured relative to pregnancy Recommended Dietary Allowances, compared with the average of leading prenatal brands and Needed's Prenatal as of December 2025. Brand A: 7x; Brand B: 6x; Brand C: 6x; Brand D: 13x.

§ Four times more nutrition refers to the average amount of vitamins and minerals provided per daily serving, measured relative to pregnancy Recommended Dietary Allowances, compared with the average of the leading prenatal gummy and capsule brand and Needed's Prenatal as of May 2026. Brand B: 4x; Brand C: 4x; Brand D: 4x.

Disclaimer

This content is a sponsored release distributed on behalf of Needed. Better Business Advice conducted an independent review based on publicly available information, product details, and brand-provided materials.

More About Needed and Needed Labs

Needed is a women's nutritional supplement company founded by two mothers and trained nutritionists who discovered firsthand that women are nutritionally depleted at the most critical moments of their lives, including during pregnancy, postpartum, and perimenopause. Its formulations are developed in collaboration with clinicians and researchers and designed to reflect modern research around women's actual nutritional needs.